Cargando…
B cell depletion in diffuse progressive systemic sclerosis: safety, skin score modification and IL-6 modulation in an up to thirty-six months follow-up open-label trial
INTRODUCTION: An over-expression of CD19 has been shown in B cells of systemic sclerosis (SSc) and B cells are thought to contribute to the induction of skin fibrosis in the tight skin mouse model. The aim was to define the outcome on safety and the change in skin score after rituximab therapy in SS...
Autores principales: | Bosello, Silvia, De Santis, Maria, Lama, Gina, Spanò, Cristina, Angelucci, Cristiana, Tolusso, Barbara, Sica, Gigliola, Ferraccioli, Gianfranco |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2888203/ https://www.ncbi.nlm.nih.gov/pubmed/20338043 http://dx.doi.org/10.1186/ar2965 |
Ejemplares similares
-
Characterization of inflammatory cell infiltrate of scleroderma skin: B cells and skin score progression
por: Bosello, Silvia, et al.
Publicado: (2018) -
Multifaceted Functional Role of Semaphorins in Glioblastoma
por: Angelucci, Cristiana, et al.
Publicado: (2019) -
Leuprorelin Acetate Long-Lasting Effects on GnRH Receptors of Prostate Cancer Cells: An Atomic Force Microscopy Study of Agonist/Receptor Interaction
por: Lama, Gina, et al.
Publicado: (2013) -
Very early rheumatoid arthritis is the major predictor of major outcomes: clinical ACR remission and radiographic non-progression
por: Bosello, Silvia, et al.
Publicado: (2011) -
Systemic Bone Density at Disease Onset Is Associated With Joint Erosion Progression in Early Naive to Treatment Rheumatoid Arthritis: A Prospective 12-Month Follow-Up Open-Label Study
por: Bruno, Dario, et al.
Publicado: (2021)